Paradigms for Treating Breast Cancers Have Changed: The One-Size-Fits-All Is no Longer True

Remy Salmon (1)
(1) Hôpital des Peupliers, Paris, France, France

Abstract

NA

Full text article

Generated from XML file

References

Waks AG, Winer EP. Breast Cancer Treatment: A Review. JAMA. 2019;321(3):288-300.

Gherghe M, Bordea C, Blidaru A. Sentinel lymph node biopsy (SLNB) vs. axillary lymph node dissection (ALND) in the current surgical treatment of early stage breast cancer. J Med Life. 2015;8(2):176-80.

Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303-10.

Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, et al. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA. 2017;318(10):918-26.

Sanz J, Zhao M, Rodriguez N, Granado R, Foro P, et al. Once-Weekly Hypofractionated Radiotherapy for Breast Cancer in Elderly Patients: Efficacy and Tolerance in 486 Patients. Biomed Res Int. 2018;2018:8321871.

Tuaeva NO, Falzone L, Porozov YB, Nosyrev AE, Trukhan VM, et al. Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements. Cells. 2019;8(10).

Authors

Remy Salmon
dr.rjsalmon@gmail.com (Primary Contact)
1.
Salmon R. Paradigms for Treating Breast Cancers Have Changed: The One-Size-Fits-All Is no Longer True. Arch Breast Cancer [Internet]. 2019 Nov. 30 [cited 2026 Jan. 12];:141-6. Available from: https://www.archbreastcancer.com/index.php/abc/article/view/263

Article Details